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INTRODUCTION 
Diabetes mellitus, the metabolic disease characterized by 
hyperglycemia results from defects in insulin secretion, insulin action or 
both. The chronic hyperglycemia of diabetes is associated with long 
term damage, dysfunction and failure of various organs like eyes, 
kidneys, nerves, heart and blood vessels. 
 Majority of cases of diabetes fall into two broad categories, Type 
1 and Type 2 Diabetes mellitus
1,2
. Type 2 Diabetes accounts for 
approximately 90 to 95 percentage  of  all diagnosed cases of diabetes. 
Long term complications of diabetes are include retinopathy, 
nephropathy and peripheral neuropathy and foot ulcers. Patients with 
diabetes have an increased risk of atherosclerotic, cardiovascular 
diseases. Hypertension and abnormalities of lipid metabolism are often 
found in diabetes. 
                            There are several pathogenic processes involved in the 
development of either form of diabetes and long term complications 
.The basis of the abnormalities in carbohydrate, fat, protein metabolism 
in diabetes is deficient action of insulin on target tissues.  Defective 
insulin action results from inadequate insulin secretion and or reduced 
tissue response to insulin action. Defect in insulin secretion or action on 
target organ frequently coexist in the same patient. Several vitamins and 
minerals act as cofactors in the enzyme reaction regulated by insulin. 
Deficiency of several vitamins and minerals such as vitamin E, 
potassium, magnesium, zinc and chromium may worse the carbohydrate 
intolerance. Of these the need for potassium or magnesium replacement 
is relatively easy to detect based on low serum levels
57
. 
Magnesium is the fourth most abundant cation in the human body 
and the second most abundant intracellular cation
32
. Magnesium plays 
an essential role in carbohydrate metabolism and in the insulin action
41
. 
Magnesium acts as a cofactor in glucose transport mechanism of the cell 
membranes and various intra cellular enzymes involved in carbohydrate 
metabolism
41,42
.The concentrations of serum magnesium in healthy 
people are remarkably constant where as30 to 35% of diabetes have low 
serum magnesium concentration
43-45
.Magnesium deficiency has a 
negative impact on glucose homeostasis and insulin sensitivity in 
patients with type 2 diabetes
46,47
 as well as the evaluation of the 
complications like retinopathy
11
 cardiovascular diseases
49
 
,nephropathy
50
  and neuropathy. Moreover, low serum magnesium is a 
strong, independent predictor of development of type 2 diabetes
51
 The 
present study was undertaken with an aim to estimate prevalence of 
hypomagnesemia in patients with type 2 diabetes and correlate serum 
magnesium concentrations with micro and macro vascular 
complications of diabetes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 AIMS AND OBJECTIVES 
 
1. Estimating  fasting serum magnesium concentration in patients with 
type 2 diabetes mellitus 
 
2. Correlating serum magnesium concentrations with micro and macro 
vascular complications of type 2 diabetes mellitus-retinopathy, 
nephropathy, neuropathy, hypertension and ischemic heart diseases   
 DIABETES MELLITUS  
Diabetes mellitus (DM) is a common  disease  of  the  general  
population worldwide  which  has as the  basic  abnormality  
hyperglycemia. Few of  the  mechanisms behind  the production  of   
hyperglycemia  include  decreased  level of   insulin secretion, reduced  
level  of   glucose utilization, and increased endogenous production of 
glucose
2
.Diabetes mellitus  causes  various  microscopic and 
macroscopic changes in  virtually all organs  of  the  body . It  is the 
major cause of cardiovascular  morbidity and mortality ,renal disease 
often progressing to end  stage  renal disease ,peripheral vascular  
disease of extremities causing non traumatic amputation of digits  and  
toes and blindness. With an increasing incidence worldwide,  diabetes  
mellitus is  expected  to  be  the  scourge  of  mankind in the near future. 
CLASSIFICATION 
Depending upon the causes that lead to hyperglycemia, diabetes 
mellitus can be classified
2
 as shown on the table : 
 Classification: 
I. Type 1 diabetes  
 In type  1 there is  beta  cell  destruction  due  to   autoimmune  
factors; this  can  be  sub classified  into  a). Idiopathic b). Immune  
mediated 
 
II. Type 2 diabetes : 
 Here   the  basic  pathology  is  not mainly  in  the  production  
of  insulin  but  rather  more  of  a  resistance  to  insulin  at  the  
receptor  level  occurs  due  to  factors  like  obesity etc, 
III. Other types of diabetes: 
a. Genetic defects of beta cell function characterized by 
mutations  in : 
i. Hepatocyte nuclear transcription factor (HNF) 4 
(MODY 1) 
ii. Glucokinase (MODY 2) 
iii. HNF – 1a (MODY 3) 
iv. Insulin promoter factor -1 (IPF-1; MODY 4) 
v. HNF-1 B (MODY 5) 
vi. NeuroD1 (MODY 6) 
vii. Mitochondrial DNA 
viii. Subunits of ATP-sensitive potassium channel 
ix. Proinsulin or insulin 
b. Genetic defects in insulin action: 
i. Type A insulin resistance 
ii. Leprechaunism 
iii. Rabson – Mendenhall syndrome 
iv. Lipodystrophy Syndromes 
c. Diseases of the exocrine pancreas – Pancreatitis, 
Pancreatectomy, Neoplasia, Cystic fibrosis, 
Hemochromatosis  
d. Endocrinopathies – Acromegaly, Cushing’s syndrome, 
Glucagonoma, Pheochromocytoma, Hyperthyroidism 
e. Drug-or chemical – induced – Glucocorticoids, Vacor (a 
rodenticide), Pentamidine, Nicotinic acid, 
f. Infections – Congenital rubella, Cytomegalovirus, 
Coxsackievirus. 
g. Uncommon forms of immune – mediated diabetes – “Stiff-
person” syndrome, Anti-insulin receptor antibodies. 
h. Other genetic syndromes sometimes associated with 
diabetes – Wolfram’s syndrome, Down’s syndrome,  
IV. Gestational diabetes mellitus (GDM) 
 Currently the terms insulin-dependent diabetes mellitus (IDDM) 
and non-insulin-dependent diabetes mellitus (NIDDM) are   obsolete
2
.                                                                                                                                                                                                                  
TYPE 1 DIABETES MELLITUS 
 Type 1 DM is due to destruction of majority of   the pancreatic 
beta cells which leads to insulin deficiency. It is not due to a single 
etiology but a complex interplay of genetic autoimmune and 
environmental factors.  The  trigger for  destruction of  beta  cells may  
be  an  infectious  process  like coxsackie , rubella, and  entero viruses or  
environmental  factors like  bovine milk proteins, and  chemicals like 
nitrosourea
1 
 The concordance of type 1 DM in identical twins ranges from 40 
to 60%
2
. The major susceptibility gene for type 1 DM is located in the 
HLA region on chromosome 6. Polymorphisms in the HLA complex 
carries 40-50% of the genetic risk to develop type 1 DM. Most 
individuals with type 1 DM have the HLA DR 3 and / or DR4 
haplotype. With type 1 DM. most strongly associated haplotypes are 
DQA 1*0301, DQB1 *0302, and DQB1 *0201. Insulin, glutamic acid 
decarboxylase, ICA-512/IA-2 and a beta cell-specific zinc transporter 
(Zn T-8).are major target for autoimmune destruction
2 
As  the  basis  of  diabetes is  believed to be  autoimmune  there  
is  an  association with  other auto immune disorders like Graves 
disease, Hashimoto thyroiditis, Addison’s disease, Vitiligo, Celiac sprue 
and Pernicious anemia
2 
  
TYPE 2 DIABETES MELLITUS 
Type 2 diabetes  mellitus is  not  associated  with  predominant  
destruction of  beta  cells as in type 1 diabetes; here  the onus is  more 
on relative or  absolute resistance  to the  action  of  insulin at the  
receptor  level; there  is  abnormal  release  of insulin  in  response  to a  
glucose load and  symptoms do not develop till the  insulin  secretion  is  
grossly  inadequate. 
Type 2 DM is polygenic. If both parents of an individual have 
type 2 DM, the risk of that individual acquiring diabetes approaches 
40%. The concordance of type 2 DM in identical twins is between 70 
and 90 %
2
. Many first-degree relatives of individuals with type 2 DM; 
though they don’t manifest overt diabetes have insulin resistance. In 
addition to genetic susceptibility, factors like obesity, physical inactivity 
and lack of exercise, improper diet modulate the clinical expression of 
diabetes mellitus. 
 Type 2 DM is characterized by impaired insulin secretion, insulin 
resistance, excessive hepatic glucose production; even fat metabolism is 
abnormal. More  than  80 %  of  diabetic  patients  are  obese with  a  
predilection for  central or  visceral obesity which can be gauged by 
waist hip ratio
2
 
 RISK FACTORS FOR TYPE 2 DIABETES MELLITUS
2 
Family history of diabetes (i.e. parent or sibling with type 2 diabetes) 
Obesity (BMI>25kg/m
2
) and Physical Inactivity 
Race/Ethnicity (e.g. African American, Latino, Native American, Asian 
American, Pacific Islander) 
Previously identified with IFG, IGT, or an A1C of 5.7-6.4% 
History of GDM or delivery of baby > 4kg (9lb) 
Hypertension (blood pressure >140/90 mmHg) 
HDL cholesterol level <35 mg/dL (0.90 mmol/L) and/ or a triglyceride 
level > 250 mg/dL (2.82 mmol/L) 
Polycystic ovary syndrome or acanthosis nigricans 
GESTATIONAL DIABETES MELLITUS (GDM) 
In females sometimes a relative insulin deficiency develops for 
the first time during pregnancy. This has been termed gestational 
diabetes mellitus. In pregnancy there is an increase in  insulin 
requirement and  also  the metabolic milieu of the body is altered  by  
pregnancy  hormones  leading  to  impaired  glucose tolerance or  frank 
diabetes.GDM occurs in 7% (range 2-10%) of pregnant  females. 
Usually they revert to normal glucose tolerance in the postpartum state 
but some have a substantial risk (35-60%) of developing DM in the next 
10-20 years
1
.  
EPIDEMIOLOGY 
The disease  burden  of  type  2  DM is  increasing  at  an  
alarming rate  when  compared  to  type  1  DM .This can  be  ascribed 
to the  changing  lifestyle of  modern  man with altered diet and  a  
sedentary  lifestyle. 
 In 2010 around 1.6 million individuals were diagnosed to have 
newly detected diabetes mellitus
1
. In 2010, the prevalence of DM is 
0.2% in individuals aged <20 years and 11.3% in individuals aged >20 
years. In individuals aged >65 years, the prevalence of DM is 26.9%. In 
both the sex the prevalence is similar in throughout the age ranges 
(11.8% and 10.8% respectively, in individuals aged >20 years). In 2030 
the greatest number of individuals with diabetes will be in the age group 
of 45-64 years
2
 
DIAGNOSIS 
A person’s handling of his glucose load may place him into any 
of the following   three categories 1. Frank diabetes mellitus 2. Impaired     
glucose tolerance    3. Normal glucose homeostasis                                                                                                                                                                                                                                                                  
Normal glucose tolerance is defined as when an FPG 100 mg/dL, 
plasma glucose <140 mg/dL 1 following an oral glucose challenge, and 
an A1C <5.6% 
2
 
 
 
CRITERIA FOR THE DIAGNOSIS OF DIABETES MELLITUS
1 
 Symptoms of diabetes plus random blood glucose concentration    
> 11.1 mmol/L (200 mg/dL) or 
 Fasting plasma glucose > 7.0 mmol/L (126 mg/dL) or  
 A1C> 6.5%  or 
 Two – hour plasma glucose > 11.1 mmol/L (200 mg/dL) during 
an oral glucose tolerance test
 
 
An FPG > 7.0 mmol/L (126 mg/dL), a glucose > 11.1 mmol/L 
(200 mg/dL) 2 hrs after an oral glucose challenge, or an A1C >6.5% 
warrant the diagnosis of DM
1
. A random plasma glucose concentration 
>11.1 mmol/L (200 mg/dL) accompanied by classic symptoms of DM 
(polyuria, polydipsia, weight loss) also is sufficient for the diagnosis of 
DM  
In asymptomatic individuals Fasting plasma glucose and HbA1c 
are the most reliable and convenient tests for diagnosing DM
2
.   
Nowadays  FPG  or the A1c  may be used as a screening test 
,because most of the  individuals who meet the current criteria for DM 
are asymptomatic and unaware of their  predicament; persons of  
diabetes  mellitus when  first  diagnosed  itself   may  have  
complications ; early  treatment may  alter  the  disease  course so  that  
a better  screening  procedure  is  always  needed
2
.  
ADA  recommends  screening  of  all  individuals  >45 yrs  every 
3 years and at an earlier age if BMI >25kg/m
2
. 
COMPLICATIONS OF DIABETES MELLITUS 
    Acute  complications  may  be  one  of  excess or  deficiency as  
in  diabetic ketoacidosis ,hyperglycemic non ketotic coma and 
hypoglycemic  illness  respectively.                                                                                                                          
 Chronic complications of diabetes mellitus may be micro 
vascular affecting the  eye, nervous system and  kidneys  or  macro 
vascular affecting  the  heart , peripheral arteries and arteries of  the  
central nervous system ; other  than  this  broad  classification of  
vascular  complications diabetes  is  a  universal pathogen of all organs 
in the human body affecting  gastrointestinal (gastro paresis, diarrhea), 
genitourinary (uropathy/sexual dysfunction),systems, skin, lens of the 
eyes, and hearing apparatus 
TREATMENT GOALS FOR DIABETES IN ADULTS
2 
HbA1c < 7 % 
Preprandial CPG 3.9-7.2 mmol/l (70-130 mg/dl) 
 
            Peak postprandial CPG <10.0 <1.7 mmol/l (<180 m 
 
<10.0 <1.7 mmol/l (<180 mg/dl) 
 
Blood pressure < 130 / 80 mmhg 
LDL < 100mg/dl  
 
HDL > 40 mg /dl-males ; > 50 mg/dl 
females 
TGL < 150 mg/dl 
 
 
NUTRITIONAL RECOMMENDATIONS FOR ADULTS WITH 
DIABETES
2 
Fat in diet :-Minimal Trans fat consumption 
Carbohydrate in diet: 
 Monitor carbohydrate intake in regards to calories ;Sucrose-
containing foods are better to be restricted  
 Glycemic index reflects  how consumption of a particular food 
affects the blood glucose 
Protein in diet: as part of an optimal diet 
Other components: 
 Routine supplements of vitamins, antioxidants, or trace elements not 
advised. 
 
DIABETES MELLITUS AND CARDIOVASCULAR MORBIDITY 
An increase in the incidence of sudden death, congestive heart 
failure and coronary atherosclerosis in diabetics has been conclusively 
proven by the landmark Framingham study. The American Heart 
Association has classified Diabetes mellitus as a CHD risk 
equivalent
1
.The risk for MI in Type 2 diabetes patients without a prior 
MI is equivalent to that of risk of MI in  nondiabetic individuals who 
have had a prior MI. Diabetic patients are prone to have myocardial  
infarction without any pain as aptly described by the acronym silent 
killer; atherosclerosis affects multiple coronary vessels at the same time 
in diabetics when compared to non diabetics; As the prevalence of 
vascular morbidity due to atherosclerosis is more in diabetics it is better 
to screen for underlying ischemic heart  disease and peripheral  arterial  
disease. Dyslipidemia, hypertension, obesity, reduced physical activity, 
and cigarette smoking increase the occurrence of macro vascular 
complications in diabetics; Most of the diabetics have 
hypertriglyceridemia and reduced HDL cholesterol levels. The  disease  
state  itself   has  no  role  in  increasing LDL levels  per se but  the  type  
of  LDL  so  called  small dense  type  of  LDL is more  atherogenic 
because  it  is  liable  to  oxidation  more  easily.  
Albuminuria, an elevation of serum creatinine, and abnormal 
platelet function are other  abnormalities found in  increased incidence  
in  diabetic  patients .Even  if  there  is  no  frank  diabetes insulin  
resistance per  se  carries an increased  risk  of  damage  to  the  heart.  
Such individuals have elevated levels of plasminogen activator 
inhibitors (especially PAI-1) and fibrinogen, which aids and   
accelerates the coagulation process and deters fibrinolysis, thus 
providing a thrombogenic milieu. Diabetics  tend  to  have  more  
frequent and  more  severe episodes of  congestive  heart  failure. There 
is  increased  myocardial cell dysfunction due  to chronic hyperglycemia 
which predisposes to frequent failure of a weak heart.  Smoking and 
hypertension when associated with diabetes mellitus become a 
formidable risk association causing more morbidity. 
DIABETIC NEUROPATHY 
Among   the  causes  of  peripheral neuropathy diabetes  mellitus  
is  one of the  foremost ; longer  duration  of  diabetes , poorer  control  
of   diabetes , development of retinal  disease  and  renal  disease are 
indicators of increased risk for neuropathy. 
                
CLASSIFICATION OF DIABETIC NEUROPATHY 
Somatic: 
 Polyneuropathy 
Symmetrical, mainly sensory and distal 
Asymmetrical, mainly motor and proximal (including 
amyotrophy) 
 Mononeuropathy (including mononeuritis multiplex) 
Visceral (autonomic): 
Cardiovascular  Sudomotor 
    Gastrointestinal  Vasomotor 
    Genitourinary                                         Pupillary 
 Diabetic neuropathy presents usually as a distal symmetrical 
polyneuropathy. The  patient  will have  progressive  sensory loss  
affecting  all modalities starting  in legs and moving up; usually as the 
duration of diabetes increases there is development of  associated 
autonomic neuropathy; patients afflicted with autonomic neuropathy 
have  abnormal sweating, abnormal  temperature regulation, dry eyes 
and mouth, pupillary abnormalities, cardiac arrhythmias, postural 
hypotension, gastro paresis, postprandial bloating, chronic diarrhea or 
constipation, impotence, retrograde ejaculation, incontinence. 
 One-third of patients have radicular involvement; they have 
severe pain in the low back, hip, and thigh in one leg. Rarely, the 
symptoms begin in both legs simultaneously. Within a few days or 
weeks, atrophy of muscles becomes apparent. 
Peripheral  mononeuropathy and cranial mononeuropathy are also 
common; of  these median neuropathy at the wrist ,ulnar neuropathy at 
the elbow,  peroneal neuropathy at the fibular head, and sciatic 
neuropathy occur  commonly  and  among  the  cranial nerves  seventh 
nerve palsy is most common, followed by third nerve, sixth nerve, and  
less frequently, fourth nerve palsies. Diabetic third nerve palsies are 
characteristically pupil sparing. 
DIABETIC NEPHROPATHY 
Of all the  causes of renal disease in  the  present  world diabetes  
is the most commonly implicated. Hyperglycemia, hypertension, 
dyslipidemia, smoking a family history of diabetic nephropathy, and 
gene polymorphisms  of the renin-angiotensin – aldosterone axis are  
associated  with  increased  risk of renal disease. 
 The basic anomaly is the presence of glomerular hyperfiltration. 
Albuminuria is the indicator of renal damage, seen in around 40% of 
diabetic nephropathy patients.  Microalbuminuria is excretion of 
albumin in the range of   30 – 300 mg/ 24 hrs; latent period for 
development of microalbuminuria is usually 5 – 10 years in type 2 
diabetic patients. Screening   for  proteinuria is  advised at the time of 
diagnosis and every 5 years in type 1 diabetes whereas in type 2 
diabetes, screening is advised at the time of diagnosis and every year 
thereafter
2
. 
        Diabetic retinopathy seen in more than 90% of patients with type 1 
diabetes and nephropathy; whereas only 60% of patients with type 2 
diabetes with nephropathy have diabetic retinopathy.  The presence of 
Kimmelstiel-Wilson nodules correlates well with the onset of 
retinopathy
2
. 
DIABETIC RETINOPATHY  
     Diabetes mellitus is the major cause of blindness between 20 to 
74 years of age group. Diabetic patients are 25 times greater risk to 
become blind than persons without DM. Individuals with >20yrs of 
duration diabetes are more prone to develop retinopathy .In type 2 DM 
around 21% of patients have retinopathy at the time of diagnosis                                                               
  UKPDS study revealed that 35% reduction in the risk of 
development of retinopathy for every percentage reduction of HbA1c
48
 
and tight BP control results in 34% reduction in progression of 
retinopathy
54
.More than 90% type1 DM nephropathy patients have 
diabetic retinopathy, where as only 60% of diabetic nephropathy have  
retinopathy. 
                  
MAGNESIUM HOMEOSTASIS 
Introduction : 
Magnesium (Mg) is the fourth most abundant cation and second 
most abundant intracellular cation
55
. Magnesium plays an essential role 
in a wide range of fundamental biological reactions
32
. Kruse and 
associates made the first systemic observations of magnesium deficiency 
in rats and dogs
22
.Early description of clinical depletion of magnesium 
in man published in 1934
23
  
Distribution :                                                                                                                                                                                                                      
Bone has the maximum content of magnesium in the body with 
more than 50 % segmented in it
32
. Rest is in the soft tissues; the total 
intracellular content of mg is    8 to 10 mmol/l
33
. Approximate daily 
intake averages between 250 – 300 mg/day; fecal excretion is 2.5 mg / 
kg / day; urinary excretion is 1.5 mg/ kg/day
55
.     
 
                                          
Total body content 24 g in adult man 
Bone  > 50 % 
Extracellular fluid  1 % 
Serum  1.7 – 2.4 mg /dl 
Ultrafiltrable Mg  75 % 
Ionized  60 % 
Complexed  15 % 
Protein bound  25 % 
 
Role of intestine: 
About 30-40% of ingested magnesium is absorbed, in the small 
intestine mainly in jejunum and ileum. This absorption is enhanced by 1, 
25 (OH)2 Vitamin D
45,55
. Growth hormone slightly increases Mg 
absorption. Aldosterone and Calcitonin appear to reduce it. Vitamin B6 
has been reported to enhance the absorption.                                                                                                
Role of kidney: 
Kidneys regulate the excretion of magnesium and thus form the 
main control of plasma levels
4
. Around 25% of filtered Mg is 
reabsorbed in the proximal tubule and 65% is reabsorbed in thick 
ascending loop of Henle and 5% in distal convoluted tubule
33
. Para 
thyroid hormone, Vasopressin, calcitonin, glucagon increase tubular 
magnesium reabsorption, whereas acetyl choline, bradykinin, and atrial 
natriuretic peptide stimulate urinary magnesium excretion
55 
DAILY RECOMMENDED INTAKE
2
 (mg/day) 
Age group Male needs Female needs 
9 – 13 yrs 240 240 
14 – 18yrs 410 360 
19 – 30 yrs 400 310 
31 – 50 yrs 420 320 
51 – 70 yrs 420 320 
 
Biological role of magnesium: 
Enzymes  of  the  intermediary metabolism  and  nucleic  acid  
metabolism depend  on  magnesium  for  their  effective  action. Almost 
five  enzymes  of  the  glycolytic  pathway depend on magnesium ;This 
comes as no surprise since four of the five ( hexokinase ,  
phosphofructokinase,  phosphoglycerate kinase , pyruvate kinase  and  enolase 
) ;three of the four key enzymes in the gluconeogenesis pathway require 
magnesium
41
. Lipid metabolism and RNA, DNA polymerases also need 
magnesium; transketolase reaction in thiamine metabolism; transfer of 
CO2 to biotin in carboxylation reactions; glutathione has an Mg 
requirement for its synthesis
24
. The second messenger cyclic adenosine 
monophosphate formed by the action of the enzyme adenylate cyclase is 
activated by Mg. 
HYPERMAGNESEMIA  
               Exclusive hypermagnesemia is   very rare unless there is 
underlying renal failure.  Kidneys excrete normally 250 mmol/d of 
magnesium daily
2
. 
Causes: 
1.  Impaired excretion 
  Renal failure 
                     Familial hypocalciuric hypercalcemia 
2. Rapid mobilization from soft tissues 
              Trauma, Shock, Sepsis, Cardiac arrest 
3. Excessive intake 
  Cathartics, Parenteral nutrition, Urologic irrigants 
4. Others 
  Adrenal insufficiency, Hypothyroidism, Hypothermia 
Signs and symptoms: 
Unless the  level  of  magnesium  raises above  4.8 mg / dl patients  are 
asymptomatic ; when  such  a  situation occurs three types of  
manifestations can occur namely  neuromuscular,  cardiovascular,  
hypocalcemic symptoms. 
Neuromuscular effects: 
           These are the most commonly  observed  and  most consistently  
observed effects  of  hypermagnesemia. Hypermagnesemia decreases  
the release of  acetyl choline  and suppresses the transmission across the 
neuromuscular junction  producing curare like effects
25,26
 .With  a 
plasma magnesium level  of 4.8-7.2 mg/dl patients  develop lethargy, 
drowsiness, muscle weakness, decreased deep tendon reflexes leading to 
flaccid quadriplegia, and respiratory  depression  
Cardiovascular effects: 
          Bradycardia and hypotension occur at plasma concentration of 
4.8-6mg/dl.    At concentration of 6 to 12g/dl prolongation of PR 
interval, widening of QRS duration and increase in QT interval occur. 
At plasma concentration of 18 mg/dl complete heart block and cardiac 
arrest can occur
27 
Hypocalcemic effects: 
 Moderate hypermagnesemia can inhibit the secretion of parathyroid 
hormone, causing reduction in plasma level of calcium causing 
hypocalcemic symptoms
28
                                                                                                                                                                                                                                                                                                                     
Other symptoms: 
   Nonspecific symptoms like nausea, vomiting and flushing can occur 
 
Treatment: 
             Maintain hydration 
             Calcium 100-200mg over 1-2 hrs intravenously given, can 
improve symptoms temporarily 
           Treatment of the cause for Hypermagnesemia 
           Haemodialysis is effective and required in case of renal failure 
 
 
HYPOMAGNESEMIA 
      Hypomagnesemia refers to low serum magnesium concentrations, 
clinically it is defined as serum concentration less than or equal to1.6 
mg/dl or >2 SD below the mean general population
16,29
. In patients 
suspected with magnesium deficiency a low serum magnesium 
concentration is sufficient to confirm the diagnosis
57
. 
Causes of Hypomagnesemia
2
:
 
1. Drugs and toxins 
  Ethanol 
Diuretics 
Cisplatin 
  Aminoglycosides 
2. Renal diseases 
  Tubulointersitial disease 
  ATN diuretic phase 
Renal transplantation 
Gitelman syndrome 
Barters syndrome 
3. Intestinal disorders 
Malabsorption syndromes 
Intestinal drainages, fistulas 
Protracted vomiting, diarrhea 
4. Metabolic causes 
Hyperaldosteronisum 
SIADH  
Diabetes mellitus 
Hypercalcemia 
Metabolic acidosis 
Hyperthyroidism 
5. Others 
Pancreatitis 
Burns 
Excessive sweating 
Pregnancy 3
rd
 trimester  
 Incidence: 
 Hospitalized patients show an increased incidence of 
hypomagnesemia with studies showing incidence of 12 %
30
. This is 
more in intensive care settings due  to  the  drugs  being  used  there ; 
studies  have  shown  incidence  of  around   60% 
31,32
.  
Symptoms and signs: 
           Only when serum magnesium concentration falls below1.2mg/dl 
symptoms and signs occur, till then usually patients are asymptomatic
56
. 
The symptoms are muscle cramps, hyperactive deep tendon reflexes, 
and dysphagia, irritability, disorientation, trousseau and chvostek signs. 
Ataxia, nystagmus and seizures occurs at the serum level of <0.8mg/dl 
.Paroxysmal atrial and ventricular dsarrhythmias may also develop. 
ECG: 
                  ECG shows nonspecific findings. Modest depletion of Mg 
(1.2 to 1.7 mg/dl) leads to QRS complex widening with peak T waves, 
where as severe magnesium depletion (<1.2mg/dl) shows PR interval 
prolongation, progressive widening of QRS complex, flattening or 
inversion of T waves and U waves
58
 
Lab studies: 
                  Because of only small fraction of magnesium present in ECF 
the serum Mg is not a reliable indicator of total body magnesium 
depletion. Nevertheless a deficiency of magnesium is clearly present if 
serum magnesium is low
57
 .Serum magnesium is measured by calmagite 
dye method, equilibrium dialysis, atomic absorption spectrometry, ion 
selective electrodes and neutron activation analysis 
 Treatment:  
                     Asymptomatic mild hypomagnesemia can be treated with 
oral magnesium salts like magnesium chloride (MgCl2),magnesium 
oxide (MgO), magnesium hydroxide (Mg(OH2)) in dose of 40-
60meq/day, whereas  severe hypomagnesemia requires parenteral  
therapy  with magnesium chloride( MgCl2) as a continuous infusion of 
100 meq/day in case of normal renal function. During management 
serum magnesium should be monitored at intervals of 12-24hrs.  
HYPOMAGNESEMIA AND DIABETES MELLITUS   
           Most common disorder associated with magnesium depletion is 
diabetes mellitus
32, 33
. Hypomagnesemia occurs in 13.5 to 47.7% of non 
hospitalized type 2 DM patients compared to 2.5% to 15% among their 
counterparts without diabetes
16, 34-37
.There is inverse relationship 
between serum Mg levels and glycemic control
16, 34, 38-40
. 
Hypomagnesemia alters the glucose transport, and decreases the insulin 
secretion, affects the post receptor insulin signaling and interactions
60
. 
Studies show correlation between serum Mg levels and glycemic control 
and also improvement of glycemic control with Mg 
supplementation
9,35,59,
 
Causes of hypomagnesemia in Type 2 Diabetes Mellitus
3
:  
1. Decreased intake 
Poor oral intake 
Esophageal dysfunction 
 Diabetic gastro paresis 
2. Increased GI loss 
  Diarrhea due to autonomic dysfunction 
3. Increased renal loss 
  Glomerular hyper filtration, osmotic diuresis, volume 
expansion, metabolic acidosis, hypoalbuminemia, microalbuminuria, 
Overt proteinuria, Insulin deficiency or resistance status and diuretics. 
HYPOMAGNESEMIA AND ADVERSE CLINICAL EVENTS IN 
TYPE 2 DM 
                 Non enzymatic glycosylation  is the basic  process underlying  
many  of  the  long  term  complications of  diabetes  mellitus ;  low  
magnesium levels  also  play  a  role in this  regard
5
. Abou seif et al 
found that low serum magnesium is associated with defective anti 
oxidative processes in type 2 DM .Paolisso and Barbagallo et al
61
 found 
that low serum magnesium diminishes the tyrosine kinase activity and 
increases the vascular resistance by calcium. This mechanism may 
account for hypertension and peripheral insulin resistance. The 
etiological role of magnesium in  diseases  like  cerebrovascular  
disease, peripheral  vascular  disease  and   cardiac disease may  be  due  
to its  role  in   inducing atherosclerosis ;   It  is observed that the serum 
Mg has inverse association with fasting serum glucose, insulin and 
systolic arterial blood pressure
4,6
. Hypomagnesemia has been seen in 
patients with diabetic retinopathy; with lower levels carrying an 
increased risk of severe diabetic retinopathy. Corsonello et al reported 
that low serum Mg is associated with diabetic nephropathy. Recent 
retrospective studies show an association between low serum Mg and 
renal function deterioration in type 2 DM
16
. Dee leewu et al
62
 observed 
that polyneuropathy was related to the duration of disease and low 
serum Mg concentration and with supplementation of magnesium 
decreasing the incidence of neuropathy .In type 2 DM development of 
feet ulcers are associated with low serum Mg levels
21
 
MAGNESIUM SUPPLEMENTATION IN TYPE 2 DM 
      Various studies have proved that magnesium replacement can lessen 
the pathogenic factors and morbidities associated with type 2 diabetes 
mellitus like platelet reactivity, cardiovascular morbidity and insulin 
resistance
19
. In a case control study done by Paolisso et al
61
, oral 
supplementation of 250 mg twice daily decreased the insulin 
requirements especially in elderly patients. They demonstrated an 
increase in beta cell response in response to glucose and arginine. 
Magnesium supplementation has been shown to decrease systolic blood 
pressure by > 5 mm hg in diabetic patients
14
 . It also has a beneficial 
effect on lipid profile; 
 The response to insulin is increased thereby decreasing the insulin 
requirement in patients who are supplemented with magnesium. This 
has been also proved conclusively by Poonam Agrawala et al
63
 .  
 
METHODOLOGY 
Study Population: 
       Patients with type 2 diabetes mellitus admitted in general medical 
ward in Government Stanley medical college hospital. 
Methods: 
       100  patients  with  type 2 DM  who were  admitted  in  general  
medical  ward  in   Stanley  Medical College  Hospital were  randomly  
selected  for  this study . From all patients detailed history, thorough 
clinical examination and   relevant biochemical investigations were 
obtained. 
Inclusion criteria: 
              All case of type 2 DM admitted in Stanley medical hospital in 
general medical wards. 
Exclusion criteria: 
 Chronic Diarrhea 
 Malabsorption 
 Patients with Renal Failure 
 Patients on Diuretics 
 Acute Myocardial Infarction in Last 6 Months 
 Patient Having Alcohol Abuse 
 Patients Receiving Mg Supplements or Mg containing Antacid 
Investigation: 
Fasting blood glucose  
Post prandial blood sugar was measured 2 hrs after a standard meal. 
24 hr urine albumins were estimated.   
Serum magnesium - Calmagite dye with spectrophotometric testing at 530 
nm 
 Blood urea,  serum creatinine. 
 Chest X ray   ECG, Echocardiogram  
 Direct opthalmoscopy 
Nerve conduction studies 
   Normal serum magnesium was defined as 1.7 – 2.4 mg / dl.  
Patients were  divided into three groups  as follows normal 1.7-
2.4mg/dl, low <1.7mg/dl, high>2.4mg/dl .Patients were categorized on 
the basis of diabetic duration, presence of IHD, HTN, mode of 
treatment, presence/absence of retinopathy, neuropathy, nephropathy 
and glycemic control. Diabetic retinopathy were classified as 
nonproliferative diabetic retinopathy and proliferative retinopathy 
.Diabetic nephropathy was graded by using 24 hr urine albumin as 
follows no nephropathy if <30mg/24hr, microalbuminuria 30-
299mg/24hr and macroalbuminuria >=300mg/24hr; 
 
 
Statistical method: 
            Statistical method analysis was done using chi square test and 
sample variable t test to compare proportions. Results were considered 
significant at p value <0.05 
 
 
 
 
 
 
RESULTS 
 This study was composed of 100 patients of type 2 DM of 
which 54 were men and 46 were women. These patients were further 
grouped according to their age, duration of diabetes, mode of treatment, 
glycemic control, presence  or absence of co morbidities (ischemic heart 
disease and hypertension) and presence /absence of diabetic 
complications(retinopathy, neuropathy and nephropathy). 
TABLE 1: AGE DISTRIBUTION & MAGNESIUM LEVELS 
 
Age Group No of Patients % 
41 - 50 22 22.00 
51 - 60 47 47.00 
61 - 70 26 26.00 
>70                5 5.00 
Total                   100 100 
Mean 57.73 
Sd 7.90 
 
Age Group 
(Yrs) 
Hypomagnesemia Normomagnesemia Total 
N % N % N % 
41 – 50 2 4.76 20 34.48 22 22 
51 – 60 16 38.10 31 53.45 47 47 
61- 70 19 45.24 7 12.07 26 26 
≥ 71 5 11.90 0 0 5 5 
Total 42 100 58 100 100 100 
 
 In  our  study maximum  number of  diabetics  occurred in the  
age  group 51 – 70 years .Youngest  patient  in  our  study  was  of  the  
age  45 years .   The mean age of diabetic patient in our study was 57.73 
years. 
 
 In our study maximum number of hypomagnesemia patients 
occurred in the age group 61 – 70 years (45.24 %). All patients  who  
were  more  than  70  years  old  had  hypomagnesemia (100 % ) . 
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TABLE 2: AGE DISTRIBUTION 
 
 Hypomagnesemia Normomagnesemia Total 
Mean 63.14 53.81 57.73 
Sd 7.46 5.58 7.90 
t-value 7.16  
Df 98  
Significant 0.0001  Significant  
 
 
The mean age group of the patients having hypomagnesemia in 
our study was 63.14. As  the  age  increased  the  prevalence  of 
hypomagnesemia increased  and   this  association  was  statistically  
significant as  shown  by  the  p  value  0.0001 ; 
 
 
 
CHARACTERISTICS OF STUDY POPULATION 
Sl. No. Characteristics Value 
1 No of Subject 
Men 
Women 
100 
54 
46 
2 Age in Years 
Men 
Women 
57.73 ± 7.90 (45 – 82 ) 
55.69 ± 6.82 
60.13 ± 8.46 
3 Medication 
Insulin 
OHA 
 
44 
56 
4 Co morbidities 
Hypertension 
Ischemic Heart Disease 
 
10 
34 
 
5 
Diabetic Retinopathy 
NPDR 
PDR 
 
28 
6 
6 Diabetic Neuropathy 4 
7 Diabetic Nephropathy 
Microalbuminuria 
Macroalbuminuria 
14 
5 
9 
 
 
The average duration of diabetes in  our study population was 
9.39    years and range from   2 yrs  to 25  yrs ;  among the 100 patients 
44 persons were  receiving insulin and 56 persons were  receiving 
OHAs; Among these individuals 10 patients had hypertension (10%)  
and 34 patients had ischemic heart diseases (34%) total 28 patients had 
retinopathy (28%) and out of them 22 had  nonproliferative retinopathy 
and 6 had proliferative retinopathy. Total 14 patients had diabetic 
nephropathy (14%) among them 5 patients were microalbuminuria and 9 
patients were macroalbuminuria and 4 persons had neuropathy (4%). 
TABLE 3: SEX DISTRIBUTION AND MAGNESIUM LEVELS 
Sex 
Hypomagnesemia Normomagnesemia Total 
No of 
patient 
Percentage 
% 
No of  
Patient 
Percentage 
% 
No of  
Patients 
Percentage 
% 
Male 18 42.86 36 62.07 54 54.00 
Female 24 57.14 22 37.93 46 46.00 
Total 42 100 58 100 100 100 
Chi-square 3.62   
Df 1   
Significant 0.057   Not Significant   
                                                                                                                                                                        
 In our study among the 100 patients, hypomagnesemia (serum Mg 
<1.7 mg/dl) was found in 42 patients of type 2 diabetic patients.58 
patients had normal serum magnesium level. No patient had 
hypermagnesemia. No significant difference was found in the rate of 
hypomagnesemia in men and women (42.86% and 57.14% 
respectively).There was no significant statistical difference found 
between men and women  p value=0.057 
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Table 4: PREVALENCE OF HYPOMAGNESEMIA & 
DURATION OF TYPE 2 DM  
Duration of 
Diabetics ( in 
Years) 
No of  
Patients 
Patients with 
Hypomagnesemia 
Prevalence (%) 
 
00 –05 31 3 9.68 
06 – 10 33 8 24.24 
11 – 15 18 16 88.89 
16 – 20 12 9 75.00 
21 – 25 5 5 100.00 
26 – 30 1 1 100.00 
 
 Hypomagnesemia Normomagnesemia Total 
Mean 13.76 6.34 9.46 
Sd 6.20 3.78 6.14 
t-value 7.42  
Df 98  
Significant 0.0001  Significant  
  Based on duration of diabetes, we had   6 categories of patients; 1 
patient had diabetes for > 25 years. 33 patients had diabetes for almost a 
decade. 35 patients had diabetic for > 1 decade. Applying the statistical 
analysis  we found that as the duration of diabetes increases ,the 
prevalence of hypomagnesemia increases as shown by the p 
value=0.0001 
Table 5: MODE OF TREATMENT & MAGNESIUM LEVELS   
Treatment 
Hypomagnesemia Normomagnesemia Total 
No of 
patients 
Percentage 
% 
No of  
Patients 
Percentage 
% 
No of  
Patients 
OHA 7 16.67 49 84.48 56 
Insulin 35 83.33 9 15.52 44 
Total 42 100 58 100 100 
Chi-square 45.47  
Df 1  
Significant 0.0001  
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In our study among the 100 diabetic patients 56 patients took 
OHA where as 44 patients took insulin therapy. Among the OHA 
receiving individuals 49 patients had normal magnesium level and only 
7 patients had low serum magnesium level (84.48% versus 16.67%). 
Among the patients receiving insulin therapy 35 patients had low serum 
magnesium level; whereas 9 patients had normal serum magnesium 
level. This difference was statistically significant as shown by    p value 
=0.0001. 
  
  
Table 6: PREVALENCE OF HYPOMAGNESEMIA & FBS 
Fasting Blood 
Sugar (FBS) 
(mg/dl) 
No of  
Patients 
Patients with 
Hypomagnesemia 
Prevalence (%) 
 
< 90 2 0 0 
91 – 100 8 0 0 
101-110 17 4 23.53 
111-120 28 7 25.00 
121-130 23 13 56.52 
> 130 22 18 81.82 
 
 Hypomagnesemia Normomagnesemia Total 
Mean 128.83 112.40 119.30 
Sd 11.26 12.16   14.29 
t-value 6.88  
Df 98  
Significant 0.0001  Significant  
                   
 In our study, 22 patient had poor glycemic control as evidenced 
by FBS >130mg/dl (81.82%).While on treatment, the mean blood sugar 
level in patient with hypomagnesemia was 128.83 where as the mean 
blood sugar level in patients with normomagnesemia was 112.40.Thus 
the association between the poor glycemic control and hypomagnesemia 
was statistically significant as shown by the p value of 0.0001 
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Table 7: PREVALENCE OF HYPOMAGNESEMIA & HbA1C % 
HbA1c 
(%) 
No of  Patients 
Patients with 
Hypomagnesemia 
Prevalence 
(%) 
 
< 6 41 1 2.44 
6 – 7 24 8 33.33 
7 – 8 19 18 94.74 
8 – 9 13 12 92.31 
9 – 10 3 3 100 
 Hypomagnesemia Normomagnesemia Total 
Mean 7.77 5.91 6.69 
Sd 0.84 0.49 1.13 
t-value 13.93  
Df 98  
Significant 0.0001  Significant  
 
 In our study, around 35 patient had poor glycemic control as 
evidenced by HbA1c>7% (95.68%). While on treatment the mean 
HbA1c level in patient with hypomagnesemia was 7.77 where as the 
mean HbA1c level in patients with normomagnesemia was 5.91.Thus 
the association between the poor glycemic control as evidenced by 
higher HbA1c and hypomagnesemia was statistically significant as 
shown by the p value of 0.0001 
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Table 8: HYPOMAGNESEMIA & DIABETIC RETINOPATHY 
Retinopathy 
No of  
Patients 
Patients with 
Hypomagnesemia 
Prevalence (%) 
 NDPR  
    PDR 
28 
6 
22 
5 
78.57 
83.33 
No Retinopathy 66 15 22.73 
 
 Hypomagnesemia Normomagnesemia Total 
No of 
patient 
Percentage 
% 
No of  
Patient 
Percentage 
% 
No of  
Patients 
No 15 35.71 51 91.07 66 
Yes 27 64.29 7 12.50 34 
Total 42 100 56 100 100 
Chi-square 29.65  
Df 1  
Significant 0.0001  
   
Observations revealed that out of 100 diabetic patients 34 patients 
had retinopathy. Among these individuals 27 persons had low serum 
magnesium levels(64.29%). Rest of the individuals with retinopathy had 
normal serum magnesium level(12.50%).Using the statistical analysis 
by chi-square test the association between the presence of 
hypomagnesemia with retinopathy in diabetic patients was found to be  
significant  as shown by the p value of 0.0001 
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Table 9: HYPOMAGNESEMIA & DIABETIC NEUROPATHY 
Neuropathy 
No of  
Patients 
Patients with 
Hypomagnesemia 
Prevalence (%) 
 
Neuropathy 4 4 100 
No Neuropathy 96 38 39.58 
 
 
Hypomagnesemia Normomagnesemia Total 
No of 
patient 
Percentage 
% 
No of  
Patient 
Percentage 
% 
No of  
Patients 
No 38 90.48 58 100 96 
Yes 4 9.52 0 0 4 
Total 42 100 58 100 100 
Chi-square 5.75  
Df 1  
Significant 0.016  
 
 Observations revealed that out of 100 diabetic patients 4 patients 
had neuropathy. All of these individuals had low serum magnesium 
levels (100%).Using the statistical analysis by chi-square test the 
association between the presence of hypomagnesemia with neuropathy 
in diabetic patients was found to be significant as shown by the p value 
of 0.016 
 
Table 10: HYPOMAGNESAEMIA & DIABETIC 
NEPHROPATHY  
Diabetic 
nephropathy 
No of  
Patients % 
Patients with 
Hypomagnesemia 
Prevalence 
(%) 
Micro and 
macroalbuminuria 
5 
9 
14 92.86 
No Nephropathy 86 29 33.72 
 
 
 
  Hypomagnesemia Normomagnesemia Total 
No of 
patient 
Percentage 
% 
No of  
Patient 
Percentage 
% 
No of  
Patients 
No 29 69.05 57 98.28 86 
Yes 13 30.95 1 1.72 14 
Total 42 100 58 100 100 
Chi-square 17.28  
Df 1  
Significant 0.0001  
 
 In our study out of 100 diabetic patients 14 patients had the 
evidence of nephropathy (92.86%).Out of these diabetic nephropathy 
patients 13 patients were low serum magnesium level 
(30.95%).Presence of normal serum magnesium level in diabetic 
nephropathy in our study was low (1.72%).Thus the association between 
the hypomagnesemia and nephropathy in diabetic patient was found to 
be statistically significant with the p value of 0.0001  
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Table11. HYPOMAGNESAEMIA & IHD 
 
Ischemic Heart 
Disease 
No of  
Patients 
Patients with 
Hypomagnesemia 
Prevalence 
(%) 
 Present 10 8 80.00 
Not Present 90 34 37.78 
 
Treatment 
Hypomagnesemia Normomagnesemia Total 
No of 
patient 
Percentage 
% 
No of  
Patient 
Percentage 
% 
No of  
Patients 
No 34 80.95 56 96.55 90 
Yes 8 19.05 2   3.55 10 
Total 42 100 58 100 100 
Chi-square 6.59  
Df 1  
Significant 0.010  Significant  
 
A total of 10 patients had IHD. Among them 8 had low serum 
magnesium level (80%). The prevalence of IHD was 19.05% in 
hypomagnesemia patients.  The prevalence of IHD was 3.55% in 
normomagnesemia patients; thus the association between the 
hypomagnesemia and the IHD in diabetic patients was found to be 
statistically significant with p value of 0.010  
 
 Table 12:  HYPOMAGNESEMIA & HYPERTENSION 
Hypertension 
No of  
Patients 
Patients with 
Hypomagnesemia 
Prevalence (%) 
 Present 34 19 55.88 
Not Present 66 23 34.85 
 
 
 
Treatment 
Hypomagnesemia Normomagnesemia Total 
No of 
Patients 
Percentage 
% 
No of  
Patients 
Percentage 
% 
No of  
Patients 
No 23 54.76 43 74.14 66 
Yes 19 45.24 15 25.86 34 
Total 42 100 58 100 100 
Chi-square 4.08  
Df 1  
Significant 0.044  
 
In   our study there were 34 hypertensive patients .Among those 19 
patients had low serum magnesium level (55.88%).The prevalence of 
HTN was more in patients with low serum magnesium level (45.24), 
when compare to patients with normal serum magnesium (25.86) .Thus 
the difference was found to be statistically significant as shown by p 
value 0.044 
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Table 13: DIABETIC COMPLICATIONS & 
HYPOMAGNESEMIA 
Complications 
No of  
Patients 
Patients with 
Hypomagnesemia 
Prevalence 
(%) 
Retinopathy&  Neuropathy 3 3 100 
Retinopathy&  
Nephropathy 
10 9 90 
Neuropathy&  
Nephropathy 
4 4 100 
All three complications 3 3 100 
Diabetic patients with 
Complications 
53 36 67.92 
Diabetic patient without 
Complications 
47 8 17.02 
 
 Prevalence of hypomagnesemia in diabetic patients with 
complications was significantly higher when compared to diabetic 
patients with no complications (67.92% versus 17.02%).The difference 
was statistically significant with p value less than 0.05.  
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DISCUSSION 
 Many  studies  have  proven  beyond  doubt  the  association  
between   the  presence  of  hypomagnesemia  and  diabetes  mellitus  ; it  
has  also  been proven  that  hypomagnesemia  has  been  associated  
with  increased  incidence  of  complications  in  diabetics
7
;  hence  I  
found  it  worthy  to   take  up  this  study  in  our  settings. 
DIABETES & HYPOMAGNESEMIA: 
 Previous studies by Nadler JC
43
 and Rude RK
45
 have reported low 
serum magnesium status in patients with type 2 DM. The reported 
prevalence of  hypomagnesemia  ranged from 13.5% to 47.7%  in type 2 
DM patients according  to Pham PC , Pham PM ,Miller JM et al
3
 .In our 
study there  were  a  total  of  100  diabetic  patients ; among  them   42 
patients  had  serum Mg below  the  reference  range;. Prevalence of 
hypomagnesemia in type 2 diabetes mellitus  according  to  our study 
was similar to that reported by Nadler et al
43
 .Walti mk et al
36
  reported 
that prevalence of hypomagnesemia in type 2 diabetes at 37.6% versus 
10.9% in non diabeteic controls in a study conducted in, Switzerland; 
this  too is  in  concordance  with  our  study  results ; 
 The causes for the high prevalence of hypomagnesemia in 
diabetes  may be due to increased urinary loss, low dietary intake or 
impaired magnesium absorption compared to healthy individuals; Rude 
RK
45
 , Mc Nair P, Christiansen MS et al 
29
 in  their study  found  
excessive urinary magnesium loss in diabetes. Recently defective 
tubular reabsorption in thick ascending loop of henle is postulated, that 
results in hypomagnesemia. The reason for the tubular defect is unclear. 
In diabetes low serum magnesium status due to low dietary intake is 
unlikely. Only 5.4% of the diabetic groups and 9.1% of the control 
group in European dietary assessment studies by Walti MK 
Zimmermann et al
36
 had intake of magnesium below their individual 
requirements. In addition type 2diabetes patients with reasonable 
metabolic control absorb dietary magnesium to a similar extent as 
healthy controls. In diabetes hyperglycemia and osmotic diuresis may 
cause excessive urinary loss of magnesium and leads to low serum 
magnesium status. 
AGE, SEX IN DIABETICS &  HYPOMAGNESEMIA : 
 In  our  study maximum  number of  diabetics  occurred in the  
age  group 51 – 70 yrs( 35 patients );youngest  patient  in  our  study  
was  of  the  age  45 years ;  mean  age  of diabetic  patients in  our  
study was  57.73 ; hypomagnesemia  occurred  maximally in  the  age  
group 61 – 70yrs ( 45 % ) ; all patients  who  were > 70 years old were  
hypomagnesemic ( 100 % ) ; mean  age  of  hypomagnesemia in our 
study was 63.14 years; As the  age  increased  the   prevalence of  
hypomagnesemia  increased  in  diabetics ; p  value was 0.0001 ; 
according  to  Yajinick et al
52
  and Al Osali ME ,Al Qassabi SS et al
18
  
proved  a  significant  correlation between  age  and  magnesium  levels ; 
the  former  also  proved  a  correlation between  the  male  sex  and  
magnesium  levels ; our  study  concurred  with  the  above  studies with  
regards to age  but  not  with  sex  preponderance and magnesium  levels 
; In our  study  54  patients were males and 46  were   females ; 24 
among   the  females had  hypomagnesemia (  52 . 17 % ) ;18 of  the  
males had  hypomagnesemia ( 33 % ) ;the  association  between  gender  
and  hypomagnesemia  was  not  significant as  seen  by  the  p value 
0.057 ;  
DURATION, MODE OF TREATMENT OF DIABETES &  
HYPOMAGNESEMIA:  
Among the 100 , 64 patients had diabetes for less than  10 years ; 
among  them 11 had  hypomagnesemia ( 17 % )  ; 6 patients  had  
diabetes mellitus for > 20 years ; all 6 had  hypomagnesemia ; ( 100 % ) 
;30 patients  had  diabetes  for 10 – 20 years and  among  them 83 % had 
hypomagnesemia ; the  p value   for the  association  between the  
duration of diabetes  and  hypomagnesemia  was  significant namely 
0.0001 ; thus longer  the  duration  more  the  hypomagnesemia;  this  is  
in  concurrence  with  the  study of  Sharma A , Dabla A et al
6
  done  in 
Bikaner. 
Among  the  100 patients ,44 had  been treated  with  insulin  and  
56  had  been  on OHAs. The insulin treated  group had higher  
prevalence of hypomagnesemia ( 83% ) and  the  p  value  of  0.0001 
proves  its  statistical significance ;Yajinik et al
52
 also  proved  similarly 
; the  mechanism  could  be  due to intracellular  shifting  of  magnesium 
by insulin ; similar  results were also obtained in Alzaida et al 
53
 .  
Though  Walti  MK
36
 had  differing  results  in  his  study ;   
FASTING  BLOOD  SUGAR , HB A1C% & 
HYPOMAGNESEMIA:  
 Yajinick CS  Smith RF et al
52
   found that an  inverse relationship  
exists between fasting blood glucose ,the percentage of HbA1c and 
serum magnesium. This  was  also  corroborated by  the  study  done  by 
Alzaida A Dinneen SF
53
 ; Schlienger et al
47 
 studied the relationship of 
glycemic control and various  trace elements and reported  low serum 
magnesium status in patients with uncontrolled diabetes.  
 In our  study 22 patients  had  poor  control  of  blood  sugar  as 
evidenced  by  FBS of > 130 mg /dl ;Among  them  18 had  
hypomagnesemia ( 81.8 % ) ;51 patients  had  FBS  in the  range 101 – 
130 mg /dl ; among   them 20 had  hypomagnesemia ( 40 % . With  
statistical  analysis it  is  seen that those with  poor  blood  sugar  control  
had  higher  prevalence of   hypomagnesemia as  evidenced  by  the  p  
value  of  0.0001 which is  significant. 
 On analyzing  the  HbA1c%   results  , we found  that 3 patients  
had   values in the  range  of 9 – 10% all 3 of them had 
hypomagnesemia( 100 %) 32 patients  had  a value  in the range 7 – 9% 
among  them 30 had  hypomagnesemia (93.75 %). Only 2 % of  the  
patients who had normal HbA1c values  developed  hypomagnesemia;  
the  p value  for  this  association is  also  0.0001  making  it  statistically  
significant .This is  similar  to  the  study  of  Tosiello et al
4
 .
 
Normomagnesemic patients had better control of  FBS &  HbA1c than 
the  hypomagnesemia  groups; this is well supported  by  the  study  
done  by Prabodh ,Prakash et al
20
. 
DIABETIC RETINOPATHY &   HYPOMAGNESEMIA:  
 In  the  100 patients we  had  , 34  patients were found to have  
retinopathy , among  whom 27  had  hypomagnesemia (9 %) ; the  
percentage  of  hypomagnesemic  patients who had retinopathy was 64 
% ;  the  normomagnesemic  patients had  only 12.5 % of retinopathy ; 
the p value  indicating  the  association was 0.0001 which was 
statistically  significant ; studies  which show similar results as ours  are  
Ceriello A  et al
10,
 , McNair et al
11
,
 
De walk HV et al
5
,Hatwal A, Gujral 
AS  et al
8
 The  exact  pathogenesis  of  retinopathy  is  not  yet  proved  
although  Grafton 
42
  et  al  hypothesed  the  inositol transport  theory . 
DIABETIC NEUROPATHY & HYPOMAGNESEMIA: 
 Only  4  patients had neuropathy but  all  4  had  hypomagnesemia  
in our  study ; hypomagnesemia and  presence of  neuropathy  were 
statistically correlating  as  shown  by  the  p  value 0.016 ; One  study  
which correlates  with  our   results  by de  Lordes  Lima M , Cruz T et 
al 
9
; but  they  measured  intracellular  magnesium ;Also  Rodriguez   
morán  M  et al  showed  a  correlation  between  hypomagnesemia  and  
development of  neuropathy & foot  ulcer in diabetic  patients
21
 
  
.  
DIABETIC NEPHROPATHY & HYPOMAGNESEMIA:  
 Out of  100 , 14  patients  had  diabetic  nephropathy;13  of  the  
42  in  the hypomagnesemia  group had  nephropathy ( 30.95 % )  and 1 
out of the 58 in the  normomagnesemia  group  had  nephropathy ( 1.7 % 
). The p value too supported this association p = 0.0001. Studies  done  
by Pham PC et al
16
  and Prakash DS  Prabodh S et al
20
  support  this  
claim ; in  a  study  by  Corsanello , the  explanation for  this  
association was  provided  for  this  association ; i.e as there  is   
albuminuria  in  diabetes  mellitus , the 30 % of  the  serum Mg which is 
protein bound  might   be lost  more  in  diabetic nephropathy.  
CARDIOVASCULAR MORBIDITY & HYPOMAGNESEMIA: 
 Among  the  42  hypomagnesemia  patients, 8  had  ischemic  
heart  disease ( 19 % ) ;and  in  the  normomagnesemic  group  2  had  
ischemic   heart  disease ( 3.5 % ). The p value too is significant further 
reiterating the association ;( p = 0.01). 
19 of the 42 hypomagnesemia were hypertensives (45 %) . 
whereas in  the normomagnesemic patients 25 % were  hypertensives 
14,15
 ; p value is significant for  this  association ( p 0.04 ) ; Liao F 
,Folsom AR et al 
12 
 too did  a   similar study and  confirmed this. 
 Reffelmann
13 
  T et al found that low magnesium levels increase  
left ventricular mass , which might  prove  detrimental in the  long  run ; 
Guerrero 
17 
et al found  a  significant   association between metabolic  
syndrome , dyslipidemia  and  hypertension in patients with  
hypomagnesemia;In the Bikaner  study  Sharma
6
 et al also proved the 
correlation between hypertension and hypomagnesemia in diabetics.   
  In the  end  after  comparing  all  the  variables  and  
complications between  the  normomagnesemic  and  hypomagnesemic  
groups, it has  been found  that  complication rate  was  more  in  the  
hypomagnesemia  group( 67 %) than the normomagnesemic  group(40 
%).  
 
 The  three prominent   complications analyzed  in  the  study  
are  retinopathy , nephropathy and  neuropathy ; the p  value  that  we  
got  was  < 0.005  emphasizing  the significance of the  association ; 
Sharma et al also  found  that  hypomagnesemic  diabetic  patients  had  
more  complications  than  normomagnesemic  diabetic patients. 
 
 
 
 
  
SUMMARY AND CONCLUSIONS 
 
 In our  study  done  in  hundred  patients admitted in general 
medical ward in Stanley Medical College Hospital following 
conclusions were obtained. Summarizing  our  study : 
 42 patients had hypomagnesemia ( 42 % )  
 Youngest patient in our study was 45 years of age ; mean 
age of patients in our study was 57.73 years  
 All patients who were > 70 years were hypomagnesemic  
 As the age increased prevalence of hypomagnesemia 
increased ; this concurred with studies done before.  
 As the duration of diabetes increased the prevalence of 
hypomagnesemia increased ; this was similar to the study 
result of Sharma et al ;  
 Those who had a higher FBS and HbA1c% had higher 
prevalence of  hypomagnesemia. This concurred with 
studies done before. 
 Hypomagnesemic patients had a higher incidence of 
complications like neuropathy, retinopathy, and 
nephropathy. 
 Hypomagnesemia correlated with higher incidence of 
ischemic heart disease and hypertensive heart disease.  
 
CONCLUSION 
 
 Low serum magnesium levels are commonly seen in diabetic 
patients. 
 Hypomagnesemia is more common in diabetic patients with 
poor glycemic control. 
Hypomagnesemia in diabetic  patients  correlates  well with  duration  of   
illness, glycemic control and complications  of  diabetes  mellitus  - both 
macro vascular and micro vascular 
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PROFORMA 
 
PATIENT DETAILS  : 
 Name    : 
          Inpatient No   : 
          Age    : 
          Sex    : 
          Occupation   : 
DIABETIC HISTORY  : 
 Age of onset  : 
          Total duration  : 
 Mode of treatment  : 
  Oral hypoglycemic agents : 
 Insulin  : 
SYMPTOMS RELATED TO COMPLICATIONS : 
a) Symptoms of neuropathy 
 Postural dizziness 
 Weakness 
           Numbness / Paraesthesia 
 Bladder incontinence     
                    Impotence 
b) Symptoms of  nephropathy 
 Oliguria 
                   Oedema 
c) Symptoms of retinopathy 
                Dimness of vision 
    Blindness 
PAST HISTORY   : 
Ischemic heart disease, Hypertension,  
Chronic Kidney disease 
PERSONAL HISTORY  : 
Smoking,  Alcohol abuse  
FAMILY HISTORY  : 
          Diabetes mellitus 
          Ischemic heart disease 
          Hypertension 
 
 
GENERAL EXAMINATION :  
Pulse rate   :                          
Blood pressure  : 
         Consciousness  : 
          Orientation   : 
          Icteric/ Anemic  : 
          Cyanosis / Clubbing  
 BPPE / Puffiness of face : 
CARDIOVASCULAR  SYSTEM  EXAMINATION : 
RESPIRATRORY SYSTEM EXAMINATION : 
ABDOMINAL EXAMINATION : 
CENTRAL NERVOUS SYSTEM EXAMINATION : 
 HIGHER MENTAL FUNCTION EXAMINATION : 
 CRANIAL NERVE EXAMINATION : 
 FUNDUS EXAMINATION : 
 
 
 MOTOR SYSTEM : 
           Wasting  : 
           Power   : 
 Tone   : 
           Reflexes  : 
SENSORY SYSTEM EXAMINATION : 
INVESTIGATIONS  : 
URINE    : 
Albumin   : 
          Sugar    : 
          Deposits   : 
24 HR URINE ALBUMINURIA  : 
RENAL FUNCTION TEST :    
Urea    : 
Creatinine   :        
RANDOM BLOOD SUGAR :                                                                                                              
FASTING BLOOD SUGAR : 
POSTPRANDIAL BLOOD SUGAR : 
ELECTROLYTES   : 
 Sodium   :       
 Potassium   :         
Chloride   : 
 Bicarbonate   : 
Fasting Serum Magnesium : 
ELECTRO CARDIOGRAM : 
ECHO CARDIOGRAM   : 
NERVE CONDUCTION STUDY : 
USG ABDOMEN   : 
FASTING LIPID PROFILE  
 
 
 
 
 
 
 
 
 
 
 
       
MASTER CHART 
      Sl. 
No. Name Age Sex IP AOD DUR TRT FBS PPBS HBA1c Mg IHD HT RET. NEU. NEP. 
1 vijaya 56yrs female 11019 45yrs 11yrs oha 145 222 8.07 1.5 - - npdr - - 
2 mahesh 62yrs male 12109 55yrs 7yrs oha 132 210 7.5 2.2 - + npdr - - 
3 jegan 49yrs male 12211 45yrs 4yrs oha 101 185 6.5 1.9 - + nil - - 
4 sundar 58yrs male 12218 51yra 6yrs oha 118 167 6.9 1.2 - + npdr - - 
5 meena 69yrs female 13319 48yrs 21yrs IN. 139 189 7.2 1.3 - + npdr - - 
6 kumar 52yrs male 13869 50yrs 2yrs oha 127 192 6 1.8 + + nil - - 
7 sundar 51yrs male 13970 48yrs 3yrs oha 101 169 6.2 2.1 - - nil - - 
8 lalitha 72yrs female 13982 52yrs 20yrs IN. 120 180 7.6 1.1 - + npdr - - 
9 muthu 51yrs male 13990 44yrs 7yrs oha 101 146 6.2 1.9 - - nil - - 
10 bala 45yrs male 13998 40yrs 4yrs oha 98 139 5.9 2.1 - - nil - - 
11 malar 48yrs male 14011 41yrs 7yrs oha 132 189 6.1 2 - - nil - - 
12 anbumani 59yrs male 14112 48yrs 11yrs IN. 142 199 7.2 1.1 - - npdr - mac 
13 velan 62yrs male 14431 50yrs 12yrs IN. 128 178 7.6 1.2 - + npdr - - 
14 meenakshi 67yrs female 14532 48yrs 19yrs IN. 136 208 8 1.1 - + pdr - Mac 
15 chandran 51yrs male 14578 45yrs 6yrs IN. 109 174 5.9 1.8 + + nil - - 
16 elumalai 70yrs male 15087 51yrs 19yrs IN. 130 195 8.4 2.3 -  + pdr - Mic 
17 abdhulla 59yrs male 15289 50yrs 9yrs oha 120 178 6.2 2.2 - + nil - - 
18 madavan 53yrs male 15351 48yrs 5yrs oha 115 178 5.9 2.1 - + nil - - 
19 narayanan 48yrs male 15467 41yrs 7yrs oha 121 190 5.7 2.1 - - nil - - 
20 karthikeyan 56yrs male 15567 45yrs 11yrs IN 126 191 7.2 1.1 - - nil - mac 
21 pandiyan 62yrs male 15860 50yrs 12yrs IN. 120 188 8 1 + - nil - - 
22 anthony 60yrs male 15967 52yrs 8yrs oha 112 178 5.9 2.3 - + nil - - 
23 juli 48yrs female 15991 45yrs 3yrs oha 101 160 5.5 2 - - nil - - 
24 padmavathy 75yrs female 16011 5oyrs 25yrs IN. 141 214 6.9 1 - + pdr - - 
25 susila 65yrs female 16098 52yrs 13yrs IN. 98 145 6 1.7 - - npdr - - 
26 jothi 60yrs female 17031 53yrs 7yrs oha 101 165 5.9 1.5 - + nil - - 
27 karuppaye 68yrs female 17132 45yrs 23yrs IN. 139 222 9.1 1.2 - + nil - mac 
28 zaheera bee 52yrs female 17321 48yrs 4yrs oha 99 155 5.8 1.9 - - nil - - 
29 mohamed 47yrs male 17451 45yrs 2yrs oha 100 163 5.5 1.8 - - nil - - 
30 muniammal 70yrs female 17552 50yrs 20yrs IN. 129 192 8.2 1.1 - - nil neuropa mic 
31 raja 65yrs male 17821 52yrs 7yrs IN. 120 178 7.2 1.2 - - nil - - 
32 angammal 70yrs female 18011 55yrs 15yrs IN. 113 189 8.4 1.1 - + npdr - mic 
33 seetha 56yrs female 18092 50yrs 6yrs oha 125 209 5.8 2.2 - - nil - - 
34 muthu 53yrs male 18321 50yrs 3yrs oha 101 189 6.2 2.1 - - nil - - 
35 manivanan 48yrs male 18534 40yrs 8yrs oha 107 190 6.1 1.9 - - nil - - 
36 murugan 62yrs male 18689 51yrs 11yrs IN. 126 185 6.4 1.1 - + npdr - - 
37 pusbham 60yrs female 18698 49yrs 11yrs IN. 145 231 6.9 1.1 - + npdr - - 
38 lakshmi 61yrs female 18751 53yrs 7yrs oha 134 189 5.8 2.3 - - nil - - 
39 anandhan 56yrs male 18761 48yrs 8yrs oha 98 156 5.4 2.1 - - nil - - 
40 ramesh 50yrs male 18831 45yrs 5yrs oha 116 189 6.1 2 niil - nil - - 
41 alem bee 63yrs female 19011 46yrs 17yrs IN. 111 177 5.9 1.9 - - npdr -  - 
42 andalammal 70yrs female 19023 53yrs 17yrs IN. 109 167 8.9 1.2 - + npdr - - 
43 dhanam 58yrs female 19078 50yrs 8yrs oha 120 180 5.7 1.8 - - nil - - 
44 lakshmi 55yrs female 19678 49yrs 6yrs oha 103 156 5.5 2.1 - - nil -  - 
45 amaravathy 70yrs female 19689 52yrs 18yrs IN. 128 208 7.8 1.1 + + pdr neuropa mac 
46 muthu 58yrs male 19711 48yrs 10yrs IN. 135 234 6.9 1 - - npdr - - 
47 mani 55yrs male 19845 51yrs 4yrs oha 111 189 5.5 2.3 - - nil - - 
48 kathiravan 50yrs male 19878 47yrs 3yrs oha 97 156 5.8 1.9 - - nil -   
49 murugan 52yrs male 19931 50yrs 2yrs oha 103 170 6 1.8 - - nil - - 
50 kristoper 49yrs male 19967 41yrs 8yrs IN. 108 190 6.5 1.1 - - nil - - 
51 devi 48yrs female 20012 45yrs 3yrs oha 117 169 6.1 1.8 - - nil - - 
52 uma 50yrs female 20045 47yrs 3yrs oha 89 152 5.7 1.9 - - nil - - 
53 mangammal 75yrs female 20089 50yrs 25yrs IN. 129 189 8.4 1.2 - + npdr - mac 
54 kuppu 68yrs female 20131 52yrs 16yrs IN. 140 190 7.4 1.1 - - npdr - - 
55 malarkodi 54yrs female 20341 45yrs 9yrs oha 114 178 6.1 2.1 - - npdr - - 
56 kamatchi 60yrs female 20467 48yrs 12yrs IN. 120 201 8.2 1.1 - - npdr nbil - 
57 bala 48yrs male 20489 45yrs 3yrs oha 87 143 5.4 2.2 - - nil - - 
58 jeyaraj 60yrs male 20567 47yrs 13yrs IN. 121 194 7.6 1 + + nil - - 
59 raman 55yrs male 20589 50yrs 5yrs oha 111 158 5.5 2.4 - - nil - - 
60 vadivelan 68yrs male 20598 50yrs 18yrs IN. 101 170 5.9 2.1 - + npdr - - 
61 yesu 56yrs male 20875 42yrs 14yrs IN. 121 189 6.2 2.1 - + npdr - - 
62 rajan 61yrs male 20942 50yrs 11yrs IN. 141 190 7.5 1.2 - - nil - - 
63 banu 48yrs male 20978 40yrs 8yrs oha 101 167 5.9 2.3 - + nil - - 
64 alagar 59yrs male 21123 52yrsw 7yrs oha 115 178 5.2 1.9 - - nil - - 
65 ammu 60yrs female 21341 45yrs 15yrs IN. 129 189 7.9 1.3 - - npdr l- - 
66 baskaran 49yrs male 21451 40yrs 9yrs IN. 115 156 5.8 1.8 - - nil - - 
67 suresh 50yrs male 21551 47yrs 3yrs oha 98 146 5.4 2.1 - - nil - - 
68 kumar 62yrs male 21768 46yrs 16yrs IN. 126 193 8.9 1.2 - - nil - mac 
69 stalin 56yrts male 21983 50yrs 6yrs oha 117 182 5.7 2.1 - + nil - - 
70 senthil 58yrs male 22051 55yrs 3yrs oha 101 168 5.5 2.3 - - nil - - 
71 arokiyam 65yrs male 22976 48yrs 17yrs IN. 135 245 9.2 1.1 + - pdr - --- 
72 arul 63yrs male 23674 51yrs 12yrs IN. 132 223 8.7 1.1 - - pdr - - 
73 prakasam 51yrs male 25438 47yrs 4yrs oha 95 178 5.5 2.4 - - nil - - 
74 kala 56yrs female 25798 46yrs 10yrs IN. 121 189 6.1 2.4 - - nil - - 
75 janaki 67yrs female 25890 55yrs 12yrs IN. 137 231 7.9 1.2 - - nil - - 
76 pandiyammal 82yrs female 26741 52yrs 30yrs IN. 145 241 8.2 1 + + npdr neurp mic 
77 perumal 78yrs male 27061 57yrs 21yrs IN. 139 221 8.8 1.1 + + npdr - mic 
78 muthu 56yrs male 27141 52yrs 4yrs oha 120 199 5.6 2 - - nil - - 
79 saravanan 49yrs male 27431 42yrs 7yrs oha 118 1899 5.9 1.8 - - nil - - 
80 krishnan 51yrs male 27561 47yrs 4yrs oha 119 178 6.1 1.9 - + nil - - 
81 vali 58yrs female 28975 45yrs 13yrs IN. 145 221 9.8 1.2 + - npdr - mac 
82 annam 60yrs female 29864 52yrs 8yrs IN. 125 216 8.7 1.1 - + npdr - - 
83 ponni 63yrs female 29880 55yrs 8yrs oha 118 187 5.9 2.4 - - nil - - 
84 kaveri 65yrs female 32171 45yrs 20yrs IN. 136 243 7.9 1.3 + - npdr - - 
85 sakthi 52yrs female 33421 48yrs 4yrs oha 129 212 7.2 1.1 - - npdr - - 
86 palani 51yrs male 33867 49yrs 2yrs oha 120 178 6.8 1.1 - - nil - - 
87 samy 49yrs male 35678 44yrs 5yrs oha 116 189 6.2 2.1 - - nil  - - 
88 thomas 58yrs male 36789 50yrs 8yrs oha 108 167 7.5 1.1 - + nil  - - 
89 bharathi 49yrs female 37821 45yrs 4yrs oha 124 179 5.5 1.9 - + nil -  - 
90 karpagam 59yrs female 39801 52yrs 7yrs oha 111 167 5.3 1.8 - + nil - - 
91 selvi 48yrs female 40124 45yrs 3yrs oha 120 157 6.1 1.7 - - nil  - - 
92 surya 49yrs female 41132 44yrs 5yrs oha 121 197 6.9 1.2 - - nil - - 
93 subha 47yrs female 42361 43yrs 4yrs oha 109 177 5.8 2.1 - - nil -  - 
94 padmini 55yrs female 42382 50yrs 5yrs oha 126 206 5.9 2.2 - - nil - - 
95 thangam 60yrs female 43351 51yrs 9yrs IN. 145 225 6 2.1 - - nil - - 
96 raman 65yrs male 45367 50yrs 15yrs IN. 135 256 8.4 1.1 - - npdr neuropa mac 
97 punitha 54yrs female 46731 48yrs 6yrs oha 123 185 6.2 1.9 - - nil - - 
98 shanthi 55yrs female 47889 47yrs 8yrs IN. 130 245 7.6 1.2 - - nil - - 
99 sarasvathy 52yrs female 48821 49yrs 3yrs oha 120 186 5.9 1.8 - - nil - - 
100 lakshmi 55yrs female 49841 48yrs 7yrs oha 124 187 5.4 2.2 - - nil - - 
 
